Continued Chemotherapy After Concurrent Chemoradiotherapy Improves Treatment Outcomes for Unresectable Cutaneous Squamous Cell Carcinoma: An Analysis of 13 Cases

Continued Chemotherapy After Concurrent Chemoradiotherapy Improves Treatment Outcomes for Unresectable Cutaneous Squamous Cell Carcinoma: An Analysis of 13 Cases

Background: There is no standard systemic therapy for unresectable cutaneous squamous cell carcinoma (ucSCC), although various chemotherapy regimens have been reported. In our department, concurrent chemoradiotherapy (CCRT) for ucSCC resulted in a 1-year survival rate similar to that of resectable c...

Full description

Bibliographic Details
Main Authors: Azusa Hiura, Koji Yoshino, Takuya Maeda, Kojiro Nagai, Satoe Oaku, Chisato Yamashita, Megumi Kato, Jiro Uehara, Yasuhiro Fujisawa
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Medicine
Subjects:
concurrent chemoradiotherapy (CCRT)
low-dose cisplatin and 5-fluorouracil
overall response rate
OS
disease control rates
1-year survival rate
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00207/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2019.00207/full

Similar Items